A Beta-Amyloid PET scan is a medical imaging technique that uses Neuraceq, a radioactive tracer, to detect the presence and amount of beta-amyloid plaques in the brain, which are a hallmark of Alzheimer’s disease. This scan can help doctors diagnose Alzheimer’s, identify people at risk of developing the disease, and monitor the effectiveness of treatments.
How it works:
1. Radioactive Tracer: A small amount of the radioactive tracer Neuraceq is injected into the bloodstream, and it travels to the brain
2. Tracer Binding: Neuraceq binds to beta-amyloid plaques in the brain
3. PET Scan: A PET scanner detects the radioactive emissions from Neuraceq, creating an image of the brain
4. Image Analysis: Doctors analyze the images to determine the amount and location of beta-amyloid plaques
Benefits of Beta-Amyloid PET scans:
● Early Detection: Allows for earlier intervention and potential benefits from new treatments
● Improved Accuracy: Can provide a more accurate diagnosis than other methods, especially in early stages of the disease
● Personalized Treatment: Helps tailor treatment plans based on the individual’s amyloid load and disease progression
A PET scan, with Neuraceq, gives your doctor information that can help assess your condition, aid in the diagnosis of Alzheimer’s Disease, or rule it out. To learn more about Neuraceq, visit https://neuraceq.com/.
